Faeth Therapeutics, Inc.
Public company- Headquarters
- AUSTIN, Texas
- Ticker
- FTH
- CIK
- 0001829802
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
2 appointments, 0 departures
Last event
Oct 27, 2026
Executive appointmentClass III director appointed: Adam Schayowitz
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class III directorAdam Schayowitz | Oct 27, 2026 | Appointed |
| Class II directorKaren Vousden, Ph.D. | Sep 17, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- Executive appointment
Class III director appointed: Adam Schayowitz
Adam Schayowitz was named Class III director of Faeth Therapeutics, Inc., effective October 23, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: Class III director
- Executive appointment
Class II director appointed: Karen Vousden, Ph.D.
Karen Vousden, Ph.D. was named Class II director of Faeth Therapeutics, Inc., effective September 11, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 17, 2026Role: Class II director
Last verified Nov 8, 2026